Phase II clinical trial of alternate-day therapy of S-1 plus carboplatin for squamous cell lung cancer.
Not Applicable
Recruiting
- Conditions
- squamous cell lung cancer
- Registration Number
- JPRN-UMIN000013613
- Lead Sponsor
- Shimane university Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Case you are planning to radiation concurrent chemotherapy.In addition, patients who had made every irradiation in 2 weeks.Came into force the definitive operation or cases of enforcement plan.Cases are complicated by serious infections.Patients with brain metastases that have clinical symptoms.Cases with pericardial effusion storage chest or ascites requiring drainage.Patients with pulmonary fibrosis or interstitial pneumonia.Mental illness to be a clinical problem.Patients with overlapping cancer activity.Cases there is a possibility that pregnant women, nursing mothers, pregnant.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method Adverse event, Biomarker, Dose Intensity